CAIRO: A total of 500,000 Hepatitis C patients in Egypt are hoped to be cured in 2016 as part of a treatment plan that includes locally-manufactured drugs, Youm7 reported Thursday.
A treatment protocol depending on the Egyptian Sovaldi and Daklinza medicines will be available at the committee, Deputy Head of National Committee to Combat Hepatitis Viruses Waheed Dous told Youm7 Thursday.
Egypt has one of the highest infection rates of Hepatitis C in the world. The country has imported Hepatitis C medicines from the U.S. since 2014, and recently began to locally produce them at subsidized costs.
The Egyptian Sovaldi will be available at less than 680 EGP/bottle at liver centers, and will be priced at 1,200 EGP/bottle at pharmacies, according to a previous announcement by the Health Ministry.
Additional reporting by Waleed Abdel Salam